Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
about
Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR ImagingCurrent trends in the surgical management and treatment of adult glioblastoma[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.Current molecular imaging of spinal tumors in clinical practice.Functional imaging in adult and paediatric brain tumours.Multimodal neuroimaging in humans at 9.4 T: a technological breakthrough towards an advanced metabolic imaging scanner.[Molecular imaging in neurological diseases].2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2Clinical value of fluorine-18α-methyltyrosine PET in patients with gliomas: comparison with fluorine-18 fluorodeoxyglucose PET.Molecular imaging of gliomas with PET: opportunities and limitations.Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPETAn intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomas.Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic Acid ((R)-, (S)-[(18)F]FAMPe) as Potential Positron Emission Tomography Tracers for Brain Tumors.The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PETNovel therapies in glioblastoma.Potential role for magnetoencephalography in distinguishing low- and high-grade gliomas: a preliminary study with histopathological confirmation.Metabolite kinetics in C6 rat glioma model using magnetic resonance spectroscopic imaging of hyperpolarized [1-(13)C]pyruvate.Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade gliomaAdvances in neuro-oncology imaging.Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized (13)C magnetic resonance spectroscopic imagingDetecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1- 13C]pyruvate and 13C magnetic resonance spectroscopic imaging.Effect of α-Methyl versus α-Hydrogen Substitution on Brain Availability and Tumor Imaging Properties of Heptanoic [F-18]Fluoroalkyl Amino Acids for Positron Emission Tomography (PET).Synthesis and evaluation of ¹⁸F labeled FET prodrugs for tumor imaging.Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis.Amino acid PET and MR perfusion imaging in brain tumours.Influence of blood-brain barrier permeability on O-(2-18F-fluoroethyl)-L-tyrosine uptake in rat gliomas.Acquisition models in intraoperative positron surface imaging.Neurologic Applications of PET/MR Imaging.Ultrasmall particles for Gd-MRI and (68) Ga-PET dual imaging.The use of hyperpolarized carbon-13 magnetic resonance for molecular imaging.Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [(18)F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience.Synthesis, characterization, and biological studies of emissive rhenium-glutamine conjugates.Preclinical characterization of 18F-D-FPHCys, a new amino acid-based PET tracer.Reproducibility of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas.MR Fingerprinting of Adult Brain Tumors: Initial Experience.Dual-time-point O-(2-[(18)F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas.Quantitative sodium MR imaging and sodium bioscales for the management of brain tumors.An SPM8-based approach for attenuation correction combining segmentation and nonrigid template formation: application to simultaneous PET/MR brain imaging.PET imaging in glioma: is it time for mainstream practice?
P2860
Q26796223-D6751385-0FE3-4693-9F1A-F31AEA85EE36Q26799854-0EE6EFCF-6841-4D3C-9D1C-A02F492C4014Q30442436-13FFE6D5-8F76-4608-8825-2F123337EBC3Q30476277-999FB507-6AF4-4B05-9A56-1593B79DE77AQ30577397-1E60C558-63AB-4C24-BEB3-CBC1D8BC8360Q30836244-274FC148-8D0C-4855-A6CC-C5468FD2CA39Q31108303-10E6DBDF-FE03-4E29-BB2F-CC5F3F70498CQ33578562-8CB7FA10-BB74-49E3-A82C-23CB11490589Q33746805-7D90BC71-62E7-4BE6-919F-93DAE0835C2FQ33961188-6CFF1F7B-9C0E-4F0B-B7E8-B86871FF9701Q34348544-6F4C8EFC-3E85-4851-AE2D-6AE4BD71583FQ35021768-9C7E638D-9227-4EAA-BC9B-D4142EE22BF5Q35156126-E7D00111-13FB-4535-91FE-31B4954D60FAQ35764792-A27FAF1F-1774-4788-ADA8-39195B981A4FQ35807945-72EFBB2C-D09D-4CE9-8D2A-33CFC7C21CB1Q35864136-5987B86A-9128-44E9-ACD4-2C41B3F8E0E8Q35914520-CA61F7AB-0952-4E59-B897-C3F874606070Q36037169-5EDEE2BD-76AB-4B02-A51A-1B2F057C4264Q36324020-1837FE81-EE68-4EE0-83A3-68F224725C89Q36339461-42030B37-C46F-4A6A-82D5-696DE6098340Q36713482-2FC1BE4D-3FCD-4F1D-9321-B47CFF0EDF1CQ36949701-081119C6-9B06-472C-AC57-257C668AED14Q37118914-17649866-60AC-4656-9D33-E8411B7FC6DCQ37494311-9E9451CC-5602-4635-BA15-EFD6E9184B96Q38561073-DAADB707-3137-4848-9FC8-57C684F474E7Q38691946-A94FE3C5-138C-4EA2-B2D2-7CD6761735B5Q38747089-30C7F186-14D4-447D-8A54-A1758E00731EQ38813902-C9A948FC-7DD4-421D-900B-EECCBA1137A2Q38846608-DD9EB86A-6EBB-4140-94AD-C1750033E43FQ38931279-232027E4-B75C-4D2C-8E34-490F5B762CA2Q38947519-38A97FB9-C8E5-4EDF-9EA4-B06F073AFFA8Q38964679-A9B5A8A5-5568-48DA-996A-5D4EFE7D276AQ39113774-E40432CD-9FFE-4C45-BF9B-5F7DFDE9956AQ39429789-AC1FA231-FB95-401B-AAF2-0497934C286FQ40232491-E53B098D-BBBC-4C79-A288-D811B7DA0933Q40402415-18240B9D-CEFB-4F7E-BEC1-90C0B327F40AQ41154181-F78AF4B8-9D1D-4397-98FC-CECEDE847FB6Q41875396-8A5119B4-C906-4DC4-9251-992A37872895Q42155937-9E9D11E7-E852-4F84-86D3-2C605C3320D1Q42332774-B4DBF7BD-990D-4EFF-B858-B8D5D10F7C61
P2860
Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
@en
type
label
Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
@en
prefLabel
Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.
@en
P2093
P50
P1476
Comparison of (18)F-FET and (18)F-FDG PET in brain tumors
@en
P2093
Ansgar Bachofner
Dirk Pauleit
Frank W Floeth
Guido Reifenberger
Hans Herzog
Heinz H Coenen
Kurt Hamacher
Michael Sabel
Paul Jansen
P304
P356
10.1016/J.NUCMEDBIO.2009.05.005
P577
2009-07-29T00:00:00Z